Condensed Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ 300,724	$ 8	$ 748,036	$ (943)	$ (446,377)
Beginning balance (in shares) at Dec. 31, 2021		81,986,192
Exercise of stock options	2,483		2,483
Exercise of stock options (in shares)		234,117
Vesting of restricted stock units		104,368
Stock-based compensation	11,939		11,939
Unrealized gain (loss) on marketable securities	(2,992)			(2,992)
Net loss	(44,617)				(44,617)
Ending balance at Mar. 31, 2022	267,537	$ 8	762,458	(3,935)	(490,994)
Ending balance (in shares) at Mar. 31, 2022		82,324,677
Beginning balance at Dec. 31, 2022	$ 214,442	$ 8	798,696	(4,575)	(579,687)
Beginning balance (in shares) at Dec. 31, 2022	82,895,718	82,895,718
Exercise of stock options	$ 1,079		1,079
Exercise of stock options (in shares)		132,191
Vesting of restricted stock units		323,869
Stock-based compensation	10,975		10,975
Unrealized gain (loss) on marketable securities	2,376			2,376
Net loss	(45,857)				(45,857)
Ending balance at Mar. 31, 2023	$ 183,015	$ 8	$ 810,750	$ (2,199)	$ (625,544)
Ending balance (in shares) at Mar. 31, 2023	83,351,778	83,351,778